Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06816927 |
| Title | Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab (GIANT) |
| Acronym | GIANT |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Duke University |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 10065 | United States | Details |
| Duke University | RECRUITING | Durham | North Carolina | 27750 | United States | Details |
| University of Texas MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
| Peter MacCallum Cancer Centre | RECRUITING | Parkville | Victoria | 3000 | Australia | Details |